Back to LYEL
NORTHERN TRUST CORP LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
10
Latest value
$215
Q3 2026
Peak value
$1.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $932K |
| Q4 2025 | $308 |
| Q1 2026 | $607K |
| Q1 2026 | $201 |
| Q2 2026 | $21K |
| Q2 2026 | $1.6M |
| Q2 2026 | $141 |
| Q3 2026 | $14K |
| Q3 2026 | $951K |
| Q3 2026 | $215 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $215 | 22 | — | — |
| Q3 2026 | $951K | 97.2K | — | — |
| Q3 2026 | $14K | 1.5K | — | — |
| Q2 2026 | $141 | 10 | — | — |
| Q2 2026 | $1.6M | 117.0K | — | — |
| Q2 2026 | $21K | 1.5K | — | — |
| Q1 2026 | $201 | 10 | — | — |
| Q1 2026 | $607K | 30.3K | — | — |
| Q4 2025 | $308 | 10 | — | — |
| Q4 2025 | $932K | 30.3K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M